chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Clavicle bone is still sore; Swelling of clavicle bone; Swollen lymph nodes; Shoulder hurt / shoulder pain; Pain at base of skull and headache; Pain in neck; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain in neck), BONE PAIN (Clavicle bone is still sore), BONE SWELLING (Swelling of clavicle bone), LYMPHADENOPATHY (Swollen lymph nodes) and ARTHRALGIA (Shoulder hurt / shoulder pain) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Heart block (30% blockage in heart), Emphysema and Bursitis (shoulder pain was diagnosed as bursitis.). Concomitant products included LOSARTAN, THYROID (ARMOUR THYROID) and SALBUTAMOL (ALBUTEROL HFA) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced NECK PAIN (Pain in neck), BONE SWELLING (Swelling of clavicle bone), LYMPHADENOPATHY (Swollen lymph nodes), ARTHRALGIA (Shoulder hurt / shoulder pain) and HEADACHE (Pain at base of skull and headache). On an unknown date, the patient experienced BONE PAIN (Clavicle bone is still sore). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, NECK PAIN (Pain in neck), BONE PAIN (Clavicle bone is still sore), BONE SWELLING (Swelling of clavicle bone), LYMPHADENOPATHY (Swollen lymph nodes), ARTHRALGIA (Shoulder hurt / shoulder pain) and HEADACHE (Pain at base of skull and headache) outcome was unknown. Not Provided          Action taken with mRNA-1273 Moderna vaccine was Not applicable   This case was linked to US-MODERNATX, INC.-MOD-2021-060224 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24-May-2021: Medical history was updated; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-060224:First dose
J&J Vaccine 4/8/21 (043A21A) COVID Positive 4/13/22  4/13/22: Patient is a 20-year-old with known history of Addison's disease.  She is under care of endocrinologist Dr.  She presented to emergency department with  nausea, chills, vomiting of 4 days duration and fever, headache of 2 days duration. Generalized headache.  No neck stiffness or neck pain. Left flank pain was rated as 8 on a scale of 1-10.  Has resolved by the time of my examination.  No aggravating or relieving factors.  Nonradiating.   She had temperature of 102.4° F on arrival in emergency department.  She had 9 bouts of emesis.  Denied hematemesis or melena.  Reported decreased urine output.  She had left flank pain which has resolved.  Symptoms reminded her of previous episodes of adrenal crisis.  While undergoing evaluation in emergency department she became hypotensive and required pressor support.   She takes hydrocortisone 20 mg in morning and 10 in evening.  She is also on fludrocortisone 0.5 mg daily.  She denied dysuria, hematuria, neck pain or neck stiffness.   She tested positive for COVID.  Denied sick contacts.  She does not remember drinking radiocontrast dye prior to CT scan.    4/16/22: Patient is a 20-year-old female with history of Addison's disease.  She was admitted on 4/14/2022 with acute adrenal crisis, UTI, dehydration, hypokalemia, and was found to be incidentally COVID positive.  She had no pneumonia on imaging.  She was admitted to the ICU and was placed on Levophed for significant hypotension.  She was also started on Levaquin for her UTI.  She received several liters of normal saline for fluid resuscitation.  Her blood pressures improved quickly and she was able to be weaned off of Levophed after several hours.  Her urine culture was positive for E coli, sensitive to Levaquin.  The patient was transferred to the medical floor yesterday.  Her vitals have remained grossly stable since that time.  This morning she reports that she feels like she is back to her baseline.  She denies shortness of breath at rest, dyspnea on exertion, chest pain, palpitations, lightheadedness, dizziness, fever, chills.  She is requesting to go home.  I discussed the case with an intensivist, who is also following with the patient.  He recommended doubling her home dose of hydrocortisone for the next 5 days, then resuming her home dose.  He will see the patient prior to discharge.
I had sores on my right big toe I also had 3 blueish colors dots on my toes. On my right middle finger and on my right index finger I had lesions and it was red in between my fingers. I went to a doctor and she gave me some medicine Clotrimazole and Betamethasone Dipropionate. It was very painful. The toe still has broken skin and it's still really dry, the skin is healing but it still does cause pain.
On the 20th in the evening it had gradiated to extreme fatigue. The 26th I got pain in my right armpit. Over a few days, 3 or 4, it seemed to travel up my under arm. Then 8 days in, the 27th, I got an oval red itchy rash at injection site for about 3 days, then on the 29th and 30th, my bottom and the sides and small amount down the back of legs started hurting really bad. Felt like bruises sometimes and sometimes like hurting skin from flu, the skin seemed a bit swollen and made indentations easy from normal sleep patterns in blankets. Not sure what else might come next....
Localized reaction at site of injection with erythema and induration secondary to Varivax.
Information has been received from a certified medical assistant referring to a patient of unknown age and gender. On 02-FEB-2015, the patient was inadvertently administered an expired dose of M-M-R II expiry date: 08-NOV-2015, (strength, lot number, route and dose were not reported). No adverse effect reported. Additional information has been requested.
swollen lymph nodes; Joint pain; This is a spontaneous report from a non-contactable pharmacist (patient). A 46-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in the left arm on 22Feb2021 at 12:30 (Batch/Lot Number: EL9269) as dose 2, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in the left arm on 29Jan2021 at 12:30 (Batch/Lot Number: EN5318) as dose 1, single for Covid-19 immunisation. The patient had no Covid prior vaccination, had not tested post vaccination, had no known allergies and had no other vaccine in four weeks. The patient experienced joint pain and swollen lymph nodes after the second dose, on 23Feb2021. No treatment was administered for the events. The events resolved in 2021.   No follow-up attempts are possible. No further information is expected.
This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP). The reporter is the patient. A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Jan2021 at 12:00 as dose 1, single (Batch/Lot number: unknown), in right arm and on 09Feb2021 at 12:00 as dose 2, single (Batch/Lot number: unknown) at the age of 68 years, in right arm for Covid-19 immunisation; CoviD-19 vaccine mRNA (mRNA 1273) (MODERNA COVID-19 VACCINE), on 23Mar2022 at 14:00 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for Covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: LEVOXYL. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "not recovered" and all described as "Treatment of COVID-19/ Paxlovid COVID rebound". Therapeutic measures were taken as a result of vaccination failure, Covid-19. The patient received Paxlovid from 16Jul2022 to 21Jul2022. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Painful swollen lymph nodes on the vaccine side 5 days after vaccination. Covid arm 7 days after vaccination
On 09/07/2022  at  01:00PM in the afternoon  I  felt like I was coming down with a cold. I had  mild symptoms such as runny nose, congestion, headache, body aches, and fever.  On the same day  I tested myself with a home test for COVID-19 which was positive. I  did a telehealth with my doctor on the same day. He prescribed  me medication for 5 days. I am not sure which medication it was but, It worked perfect.
At 3:35PM patient felt dizzy then experienced an episode of syncope in waiting room after menactra vaccine administration at 3:32 PM. No fall was witnessed as she was sitting in a chair at time of incident. Mother was with her and called for help. Within seconds of arrival, patient started to come back to. Face was pale. Voiced knowledge of name and place. Expressed nausea, no vomiting. Fasting blood sugar 104. She did eat lunch prior to coming to the office. Given water and protein bar now which she ate and tolerated well. VS 3:39PM 110/40 BP sitting, 60 pulse 40 , 99% o2 and 14 resps VS 3:40 PM BP 89/55 sitting, pulse 60 O2 99% and resps 14 VS taken at 3:57PM 90/60 BP, pulse 67, 02 97% , resps 15. Patient reported nausea resolved, color returned to face. VS 4:03 BP 89/62 , pulse 67, o2 99% and resps 15 VS 4:07 pm 85/60 O2 99%, pulse 64, resps 14 Patient expressed feeling "completely normal". Heart regular rate and rhythm, lung fields clear. Walked to car with supervision from nurse and mother. Voiced that similar experience has occurred in the past surrounding an injection. Encouraged to call the office as needed.
Site: Pain at Injection Site-Medium, Systemic: Joint Pain-Medium, Additional Details: Patient came in on 1/31/23 for a vaccine and reported Left shoulder pain immediately following Hepatitis B injection. He states he has pain lifting arm and trouble doing his normal routine exercise. Patient had not followed up with a provider for further evaluation yet.
Pt. came in for P.E. 11/27/07 - well visit; ILs administered in the morning.  In the evening pt. suddenly felt cold/chills, pain legs/shoulders, dizzy, blurred vision, pain along R wrist.  Took pt. to after hours pediatrics for evaluation.  Vision: 20/16 both eyes; see lab results; vaccine sites were not red, very mild induration; T: 98.6 degrees; SpO2: 98%; Meds: Advil 400 mg.  Still with nausea, decreased appetite, light headed. This is in follow-up to report(s) previously submitted on 1/15/2008. Information has been received from a physician concerning a 14  year old female who on 27-NOV-2007 was vaccinated intramuscularly in the left deltoid with GARDASIL (lot# 659439/1267U). Concomitant therapy included VARIVAX for the treatment of prophylaxis (duration and dose not reported). Other concomitant therapy included MENACTRA. On the evening of 27-NOV-2007 the patient experienced chills, dizziness, blurred vision and pain in the right wrist. The patient had an emergency pediatric evaluation on 27-NOV-2007 and the results were: vision fine, blood sugar 104, Hemoglobin 17.5 and hematocrit 40%, no fever, no redness and mild induration at the site of vaccination. The patient had taken ADVIL. On 28-NOV-2007 the patient experienced no appetite, lightheaded and nausea with no fever and no local reaction detected. On 10-NOV-2007 the patient was seen in the office with symptoms of headache, nausea and chills. Temporal temperature was 99.2 and blood pressure was "92/44". The left arm had minimal tenderness and right arm was slightly tender where MENACTRA was administered. Subsequently, the patient recovered from chills, dizziness, blurred vision, pain in the right wrist, no appetite, lightheaded, nausea and headache. Additional information has been requested.
3rd dose of ora typhoid 4/9/02. 4/10/02 with hives all over. Benadryl po didn't help at dr's office got Adrenalin and steroids.
19 days after receiving vaccine patient reports severe itching to the right foot. 19 days after the second vaccine dose on 4/9/21 patient experienced severe itching to the left foot. symptoms were described as debilitating. symptoms resolved on own but returned again in July. Was evaluated for this on 7/19/21, treated with Prednisone and Claritin.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concurrent conditions, medical history, or concomitant medications. On or about in 2016, a pharmacist at a pharmacy administered ZOSTAVAX to the patient to obtain permanent prevention and protection against shingles and zoster-related injuries/conditions (dose, route, and lot # not provided). In 2017, the patient was treated by a physician at an internal medicine office for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was not recovered. Causality assessment was related. Additional information has been requested.
For 3 days after the vaccines, patient states she had fever, and a sore, itchy right arm. Patient states she has pain at injection area. Pharmacist advised adverse effects can be expected, but if severe pain or discomfort, she should call MD. Customer calls pharmacist on 10-27-20 as her arm still hurts.
On 2/22/2021 at about 8:30 PM, while I was at work, I started to feel palpitations and an increased heartrate. As time went on, my heartrate continued to climb and eventually reached the 150s. My place of employment has an emergency medical team, and I went to them when I began to feel like I was going to pass out. The team hooked me up to an EKG, which indicated that my heartrate was bouncing between the 140s and 150s and that my heart was in sinus tachycardia. My blood pressure was over 200 over more than 100. (I don't remember the exact numbers.) They then recommended that I be transported by ambulance to hospital. The ambulance crew did an EKG that showed the same results as the workplace EKG, as did also the ER staff at Hospital. At the ER, I underwent a chest X-ray, which showed no abnormalities. They did bloodwork, and the troponin levels tested normal and showed no indication of a heart attack. After the results of the lab work showed normal, I was sent home and advised to see a cardiologist. About 10-14 days later, I saw a cardiologist, Dr.  Dr. gave me a halter monitor to wear for 30 days, a stress test, and a cardiac MRI. The halter monitor showed premature atrial contractions, premature ventricular contractions, and supraventricular tachycardia. I was put on metoprolol. I currently see Dr. about every 90 days, and we sort of play with the dosages to see what works best. There is nothing structurally wrong with my heart; the issue lies with the electrical signals that cause the heartbeat.
Case number PHEH2014US014988 is an initial spontaneous report received from a pharmaceutical company (Merck) on 25 Jul 2014. This report refers to a patient of unknown age and gender. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with MENVEO (batch number: not reported) on an unspecified date. The patient passed out after receiving vaccination on unspecified date. The outcome, seriousness and causality of the event were not reported.
chills; nausea; vomit; dehydration; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), NAUSEA (nausea), VOMITING (vomit) and DEHYDRATION (dehydration) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension, Cancer and Diabetic.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced CHILLS (chills), NAUSEA (nausea), VOMITING (vomit) and DEHYDRATION (dehydration). At the time of the report, CHILLS (chills), NAUSEA (nausea), VOMITING (vomit) and DEHYDRATION (dehydration) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Dec 10 2021 0800 developed atrail fib? - fluttering and flipping heart with concurrent tachycardia  (100 - 110 bpm) out of the blue.  Stopped and started for about 45 minute episode . I was anxious and pacing and almost went to the ER for assessment. Then had 3 more  5-10 minute episodes later in day. which were much less alarming.  Was fatigue for a day or 2 before and after these events. No other symptoms since.
improvement of Parkinson's symptoms after first dose; sore arm; Fever; This spontaneous case was reported by a non-health professional and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (improvement of Parkinson's symptoms after first dose), MYALGIA (sore arm) and PYREXIA (Fever) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Parkinson's disease since 2007. Concomitant products included GABAPENTIN for Neuropathic pain, CARBIDOPA, LEVODOPA (CARBIDOPA AND LEVODOPA) for Parkinson's disease.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced MYALGIA (sore arm) and PYREXIA (Fever). On 27-Mar-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (improvement of Parkinson's symptoms after first dose). On 26-Mar-2021, MYALGIA (sore arm) and PYREXIA (Fever) had resolved. On 28-Mar-2021, THERAPEUTIC RESPONSE UNEXPECTED (improvement of Parkinson's symptoms after first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Memory vitamins is known to have been used by the patient. No treatment information was provided by the reporter.   This case was linked to MOD-2021-207635 (Patient Link).
Approximately 20 hours after injection (about 7pm) I had some common symptoms. I began to develop a mild fever of 100.3, body aches, headache, swollen arm. These persisted throughout the night. I treated with Tylenol as recommended. I got a LOT of sleep and  fever and headache persisted until about noon the next day. By 4pm I was feeling good again except my lymph nodes under my left arm are swollen and are tender and painful.  I am treating the swollen lymph node pain with Tylenol. Over all the fever only lasted less than 24 hours with plenty of sleep.   It also is worth noting that my first dose I had zero side effects. These side effects from the second dose seem harmless enough and tolerable as they don't last long.
Dizzy after shot was given, small rash under chin, neck and on lower back. Patient speaks a foreign language so unable to communicate with patient to see how she is doing.
developed a little bit of headache; a little bit of body ache; This is a spontaneous report received from a contactable consumer for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 24Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 24Mar2021, outcome "unknown", described as "developed a little bit of headache"; PAIN (non-serious) with onset 24Mar2021, outcome "unknown", described as "a little bit of body ache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sore throat, sore neck, sore joint; flu-like; no rash; headache
no adverse effects; A patient received a dose of VAQTA on 01/29/2018, on 07/31/2018, and on 09/25/2019; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications or drug reactions/allergies. On 29-JAN-2018, the patient received their fist dose of hepatitis a vaccine, inactivated (VAQTA) for prophylaxis (dosage schedule, route of administration, anatomical location, lot number and expiration date were not reported). On 31-JUL-2018, the patient was vaccinated with the second dose of hepatitis a vaccine, inactivated (VAQTA) for prophylaxis (dosage schedule, route of administration, anatomical location, lot number and expiration date were not reported). On 25-SEP-2019, the patient was administered a third dose of  hepatitis a vaccine, inactivated (VAQTA) for prophylaxis (dosage schedule, route of administration, anatomical location, lot number and expiration date were not reported) (extra dose administered).    No adverse effects were reported.
ON 06/06/2021 AND 06/07/2021 PATIENT PRESENTED NAUSEA, VOMITING, AND DIARRHEA. AFTERWARDS, ON 06/08/2021 THE PATIENT ARRIVED TO THE EMERGENCY ROOM COMPLAINING WITH  SHORTNESS OF BREATH AND ACUTE LEFT SIDED PAIN.
Pt received immunization at MD's office and then went home. Pt was sleeping later when mom heard screaming. Mom went into pt's room and pt was screaming for a few minutes. Pt then went limp and pale in moms arms and wasn't responding for several minutes. EMS was called, upon arrival, pulse ox 85.5. Given 15L02 by non-rebreather and taken to ED. Admitted to hospital. Admitted for evaluation. Thought to be hyporesponsive hypotonic episode.
I had progressively increased joint pain in both shoulders to the point I sought out a pain clinic. They did an MRI and found nothing wrong. They said I had a very small tear in my muscle in the left. I didn't report initially because I didn't connect the two. Several other people I know had the exact same reaction and it all happened within two weeks of us getting our shot. The physician that is one who had it also suggested I reported it because he was one who had the reaction as well. Dr. around mid- June and had me see another doctor in his office who was orthopedic surgeon I seen another I was in pain for 6 weeks before I got the MRI and a cortisol injection right before 4th of July. The Left side was worse and I am left side dominate. I couldn't dress myself because I couldn't pull things over me and I didn't feel back to myself until late September. I have recovered.